GENPHARMASEC
|
GENPHARMASEC Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Operational & Financial Ratios | |||
| Earnings Per Share (Rs) | 0.02 | - | 0.04 |
| CEPS(Rs) | 0.04 | - | 0.02 |
| DPS(Rs) | - | - | - |
| Book NAV/Share(Rs) | 1.18 | 1.16 | 0.55 |
| Tax Rate(%) | 34.52 | 167.56 | -299.43 |
| Margin Ratios | |||
| Core EBITDA Margin(%) | 0.23 | 0.15 | 1.01 |
| EBIT Margin(%) | 6.90 | 2.17 | 1.32 |
| Pre Tax Margin(%) | 5.58 | 0.82 | 1.10 |
| PAT Margin (%) | 3.65 | -0.56 | 4.41 |
| Cash Profit Margin (%) | 6.06 | -0.42 | 4.49 |
| Performance Ratios | |||
| ROA(%) | 1.64 | -0.38 | 5.91 |
| ROE(%) | 1.90 | -0.42 | 7.34 |
| ROCE(%) | 3.43 | 1.53 | 1.83 |
| Asset Turnover(x) | 0.45 | 0.68 | 1.34 |
| Sales/Fixed Asset(x) | 7.17 | 55.92 | 166.66 |
| Working Capital/Sales(x) | 1.93 | 0.79 | 1.51 |
| Efficiency Ratios | |||
| Fixed Capital/Sales(x) | 0.14 | 0.02 | 0.01 |
| Receivable days | 122.83 | 88.89 | 81.67 |
| Inventory Days | 92.22 | 111.15 | 138.41 |
| Payable days | 65.70 | 28.23 | 21.37 |
| Valuation Parameters | |||
| PER(x) | 83.26 | - | 46.00 |
| PCE(x) | 51.24 | -970.75 | 75.24 |
| Price/Book(x) | 1.61 | 1.92 | 5.62 |
| Yield(%) | - | - | - |
| EV/Net Sales(x) | 3.04 | 3.55 | 3.42 |
| EV/Core EBITDA(x) | 32.66 | 153.69 | 244.10 |
| EV/EBIT(x) | 44.04 | 163.50 | 258.27 |
| EV/CE(x) | 1.50 | 1.60 | 4.74 |
| M Cap / Sales | 3.10 | 4.06 | 3.37 |
| Growth Ratio | |||
| Net Sales Growth(%) | 10.91 | 19.16 | - |
| Core EBITDA Growth(%) | 347.34 | 96.47 | - |
| EBIT Growth(%) | 252.87 | 95.41 | - |
| PAT Growth(%) | 827.17 | -115.05 | - |
| EPS Growth(%) | 1,086.96 | -105.67 | - |
| Financial Stability Ratios | |||
| Total Debt/Equity(x) | 0.05 | 0.05 | 0.20 |
| Current Ratio(x) | 2.78 | 15.16 | 9.17 |
| Quick Ratio(x) | 1.94 | 11.89 | 4.48 |
| Interest Cover(x) | 5.20 | 1.61 | 6.03 |
| Total Debt/Mcap(x) | 0.03 | 0.03 | 0.04 |
Compare Financial Ratios of peers of GENPHARMASEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENPHARMASEC | ₹69.8 Cr | -3.1% | -8.7% | -61.8% | Stock Analytics | |
| SUDARSHAN CHEMICAL INDUSTRIES | ₹7,187.5 Cr | -6.4% | -8.3% | -17.2% | Stock Analytics | |
| KIRI INDUSTRIES | ₹3,215.1 Cr | -2% | -4.4% | -19.5% | Stock Analytics | |
| VIDHI SPECIALTY FOOD INGREDIENTS | ₹1,693.1 Cr | -3.8% | -6.2% | -33.1% | Stock Analytics | |
| SHREE PUSHKAR CHEMICALS & FERTILISERS | ₹1,080.2 Cr | -5.8% | -12.7% | 8.7% | Stock Analytics | |
| BODAL CHEMICALS | ₹630.6 Cr | -3.7% | -4.5% | -22.9% | Stock Analytics | |
GENPHARMASEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENPHARMASEC | -3.1% |
-8.7% |
-61.8% |
| SENSEX | -1.7% |
-1.4% |
7% |
You may also like the below Video Courses
